Skip to content

Effect of esketamine on hemodynamics of cesarean section under epidural anesthesia

Effect of esketamine on hemodynamics of cesarean section under epidural anesthesia

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400088837
Enrollment
Unknown
Registered
2024-08-27
Start date
2023-12-01
Completion date
Unknown
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Incidence of hypotension during surgery

Interventions

Esketamine group:0.15 mg kg - 1 esketamine was injected intravenously after 0.75% ropivacaine 10ml was injected through an epidural catheter
Matched group:0.9% sodium chloride injection of equal volume was injected intravenously after 0.75% ropivacaine 10ml was injected through an epidural catheter

Sponsors

Guiyang maternal and child health care hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: (1)Single pregnancy full-term pregnancy cesarean section; (2)American Society of Anesthesiologists (ASA) Grade I to II (3)Women of childbearing age over 18 years old, gestational age is greater than or equal to 37 weeks (4)BMI 18~40kg/m2; (5)There are no contraindications to intraspinal anesthesia (6)Volunteer for the study and obtain informed consent

Exclusion criteria

Exclusion criteria: exclusion criteria:(1)Known allergy to esketamine;(2) Persons with mental illness or cognitive impairment who are unable to perform relevant assessments;(3)Fetal distress or abnormality, placenta previa, placental abruption. Exclusion criteria:(1) After entering the operating room, the patient had two resting periods in the supine position with SBP>140 mmHg or SBP<90mmHg; (2) The amount of blood lost during the operation exceeds 15% of the total maternal blood volume; (3) The dural membrane was accidentally punctured, the catheter was placed in the blood vessel or the subarachnoid space; (4) Patients with poor epidural anesthesia effect who need to change the anesthesia program; (5) A serious condition has occurred that may require treatment; (6) Situations in which the investigator believes that termination of the study would be beneficial to the maternal health.

Design outcomes

Primary

MeasureTime frame
Incidence of hypotension during surgery;

Secondary

MeasureTime frame
The score of VAS;sedation score;Neonatal Apgar score;

Countries

Chnia

Contacts

Public Contactzhangxingwei

Guiyang maternal and child health care hospital

1272975372@qq.com+86 159 8519 6345

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026